StonvexLoading…
StonvexStonvexStonvexCore line items from ACN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-31 | Annual 2025 2025-05-31 | Annual 2025 2025-02-28 | Annual 2024 2024-11-30 |
|---|---|---|---|---|
Revenue | $69.67B | $17.73B | $16.66B | $17.69B |
Operating Income | $10.23B | $2.98B | $2.24B | $2.95B |
Net Income | $7.68B | $2.20B | $1.79B | $2.28B |
EPS (Diluted) | $12.15 | $3.49 | $2.82 | $3.59 |
Total Assets | $65.39B | Not available | Not available | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $11.48B | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $10.87B | Not available | Not available | Not available |
Shares Outstanding | 632.44M | 630.46M | 634.21M | 634.66M |